Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;31(3):1300-1307.
doi: 10.1007/s00330-020-07139-3. Epub 2020 Sep 3.

Transhepatic stent placement for portal vein obstruction after hepatobiliary and pancreatic surgery: long-term efficacy and risk factor for stent failure

Jae Hwan Lee  1 , Chang Jin Yoon  2   3 , Won Seok Choi  1
Affiliations

Transhepatic stent placement for portal vein obstruction after hepatobiliary and pancreatic surgery: long-term efficacy and risk factor for stent failure

Jae Hwan Lee et al. Eur Radiol. 2021 Mar.

Abstract

Objectives: To evaluate the long-term efficacy of transhepatic portal vein (PV) stent placement in patients with postoperative PV obstruction and to identify risk factors for stent failure.

Methods: Between January 2007 and October 2019, percutaneous transhepatic PV stent placement was attempted in 60 patients with postoperative PV obstruction. Technical and clinical success, complications, and stent patency were retrospectively evaluated. Thirteen clinical variables were analyzed to determine risk factors for stent failure.

Results: Stent placement was technically successful in all patients. Thromboaspiration (n = 19) and jejunal variceal embolization (n = 7) were performed in the same session. Clinical symptoms related to portal hypertension were resolved in 54 patients (90.0%). There was no procedure-related complication. During the follow-up period (mean 630 days), stent failure occurred in 13 patients. One- and 5-year stent patency rate was 74.8% and 64.9%, respectively. The presence of a pancreatic fistula was the only independent risk factor associated with stent failure (HR 7.54; 95% CI 2.02-28.10, p = 0.003).

Conclusions: Percutaneous transhepatic PV stent placement is a technically feasible and effective treatment for postoperative PV obstruction. The pancreatic fistula is a risk factor for stent failure.

Key points: • Percutaneous transhepatic stent placement is an effective treatment to improve portal hypertension-related symptoms in patients with portal vein obstruction after hepatobiliary and pancreatic surgery. • The pancreatic fistula is an independent risk factor for portal vein stent failure.

Keywords: Fistula; Hypertension; Portal; Portal vein; Stents.

PubMed Disclaimer

References

    1. Kang MJ, Jang JY, Chang YR, Jung W, Kim SW (2015) Portal vein patency after pancreatoduodenectomy for periampullary cancer. Br J Surg 102:77–84 - DOI
    1. Carnevale FC, de Tarso Machado A, Moreira AM et al (2011) Long-term results of the percutaneous transhepatic venoplasty of portal vein stenoses after pediatric liver transplantation. Pediatr Transplant 15:476–481 - DOI
    1. Fujii T, Nakao A, Yamada S et al (2015) Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates. Surgery 157:708–715 - DOI
    1. Park JH, Yeo JH, Kim YS et al (2019) Portal vein stent for symptomatic malignant portal vein stenosis: a single-center experience. Curr Probl Cancer. https://doi.org/10.1016/j.currproblcancer.2019.04.002
    1. Shimizu Y, Yasui K, Fuwa N, Arai Y, Yamao K (2005) Late complication in patients undergoing pancreatic resection with intraoperative radiation therapy: gastrointestinal bleeding with occlusion of the portal system. J Gastroenterol Hepatol 20:1235–1240 - DOI

LinkOut - more resources